north-america-cancer-therapies-market-industry
Published

November 2016

North America Cancer Therapy Market - Growth, Trends, and Forecasts (2016 - 2021)

Purchase Report
$3850
Single user license
$4000
Team license
$8250
Corporate license

The North American cancer therapy market is expected to grow at a CAGR of 15.5 % and reach USD 20.1 billion by 2021.

North America Cancer Therapy Market-Market Dynamics

The report details several factors driving and restraining the market, some of which are listed below.

Drivers

  • Rise in cancer incidence
  • Increasing access to modern therapeutics
  • Increasing geriatric population
  • Increase in innovations, improvements and approvals

Restraints

The major restraints to the growth of the market are the high prices of therapy, change in reimbursement policies, and challenges faced in clinical trials.

The cancer therapy market is segmented based on therapy into targeted cancer therapy (hormone therapy, signal transduction inhibitors, gene expression modulators, apoptosis inducers, etc.), immunotherapy (monoclonal antibodies, cancer vaccines, non-specific immunotherapy), and chemotherapy.

Several major players are implementing innovations, strategies, and new product launches to gain a competitive edge. Some of these companies are:

  • AstraZeneca PLC
  • Chugai Pharmaceutical Co., Ltd.
  • Genentech Inc.
  • GlaxoSmithKline PLC
  • GPC Biotech AG
  • OSI Pharmaceuticals, Inc.

Key Deliverables in the Study

  • Market analysis for the North American cancer therapy market, with region-specific assessments and competition analysis on the global and regional scale.
  • Market definition along with the identification of key drivers and restraints.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their market.
  • Identification and analysis of the macro and micro factors that affect the North American cancer therapy market.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
  • A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
  • Insights on the major countries/regions in which this industry is growing and to also identify the regions that are still untapped.
RELATED REPORTS

Confused about which report to get?

Download a full report to understand our capabilities
Purchase Report
$3850
Single user license
$4000
Team license
$8250
Corporate license
Our Clients Include View All

Looking to Customize Report?